Yunnan Hansu Biotechnology Co., Ltd. Sustainability Profile
Yunnan Hansu Biotechnology Co., Ltd., commonly referred to as Hansu Biotech, is a leading player in the biotechnology sector, headquartered in China. Established in 2015, the company has rapidly expanded its operations across major regions in Asia, focusing on innovative solutions in the fields of health and wellness. Specialising in the development and production of high-quality CBD products, Hansu Biotech stands out for its commitment to sustainability and rigorous quality control. Their core offerings include CBD oils, edibles, and topical applications, all crafted to meet the diverse needs of consumers seeking natural alternatives. With a strong market position, Hansu Biotech has garnered recognition for its pioneering research and development efforts, positioning itself as a trusted name in the rapidly evolving CBD industry.
DitchCarbon Score
How does Yunnan Hansu Biotechnology Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Yunnan Hansu Biotechnology Co., Ltd.'s score of 5 is lower than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Yunnan Hansu Biotechnology Co., Ltd.'s reported carbon emissions
Yunnan Hansu Biotechnology Co., Ltd., headquartered in China (CN), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, the company has not established any documented reduction targets or climate pledges. In the context of the biotechnology industry, it is essential for companies to engage in climate commitments and set measurable targets to mitigate their environmental impact. While Yunnan Hansu Biotechnology Co., Ltd. has not yet outlined its climate strategy or emissions data, the industry is increasingly focusing on sustainability and carbon neutrality. As the company develops its environmental policies, it may consider aligning with industry standards and frameworks such as the Science Based Targets initiative (SBTi) to enhance its climate commitments in the future.
How Carbon Intensive is Yunnan Hansu Biotechnology Co., Ltd.'s Industry?
How Carbon Intensive is Yunnan Hansu Biotechnology Co., Ltd.'s Location?
Yunnan Hansu Biotechnology Co., Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Yunnan Hansu Biotechnology Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
